Abstract
Acute respiratory infections trigger an inflammatory immune response with the goal of pathogen clearance; however, overexuberant inflammation causes tissue damage and impairs pulmonary function. CD4+FOXP3+ regulatory T cells (Tregs) interact with cells of both the innate and the adaptive immune system to limit acute pulmonary inflammation and promote its resolution. Tregs also provide tissue protection and coordinate lung tissue repair, facilitating a return to homeostatic pulmonary function. Here, we review Treg-mediated modulation of the host response to respiratory pathogens, focusing on mechanisms underlying how Tregs promote resolution of inflammation and repair of acute lung injury. We also discuss potential strategies to harness and optimize Tregs as a cellular therapy for patients with severe acute respiratory infection and discuss open questions in the field.
Original language | English (US) |
---|---|
Article number | e170505 |
Journal | Journal of Clinical Investigation |
Volume | 133 |
Issue number | 14 |
DOIs | |
State | Published - Jul 17 2023 |
Funding
NM is supported by NIH award T32AI083216. BDS is supported by NIH awards R01HL149883, R01HL153122, P01HL154998, P01AG049665, and U19AI135964. LMN is supported by the Parker B. Francis Opportunity Award and NIH awards K08HL15935 and U19AI135964.
ASJC Scopus subject areas
- General Medicine